[go: up one dir, main page]

GB9010404D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9010404D0
GB9010404D0 GB909010404A GB9010404A GB9010404D0 GB 9010404 D0 GB9010404 D0 GB 9010404D0 GB 909010404 A GB909010404 A GB 909010404A GB 9010404 A GB9010404 A GB 9010404A GB 9010404 D0 GB9010404 D0 GB 9010404D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909010404A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Priority to GB909010404A priority Critical patent/GB9010404D0/en
Publication of GB9010404D0 publication Critical patent/GB9010404D0/en
Priority to EP91907827A priority patent/EP0530207A1/en
Priority to CA002078007A priority patent/CA2078007A1/en
Priority to PCT/EP1991/000737 priority patent/WO1991017162A1/en
Priority to JP3507697A priority patent/JPH05505199A/en
Priority to FI925054A priority patent/FI925054A7/en
Priority to PT97587A priority patent/PT97587A/en
Priority to IE155291A priority patent/IE911552A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB909010404A 1990-05-09 1990-05-09 Therapeutic agents Pending GB9010404D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB909010404A GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents
EP91907827A EP0530207A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
CA002078007A CA2078007A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
PCT/EP1991/000737 WO1991017162A1 (en) 1990-05-09 1991-04-17 Imidazopyridine paf antagonists
JP3507697A JPH05505199A (en) 1990-05-09 1991-04-17 Imidazopyridine PAF antagonist
FI925054A FI925054A7 (en) 1990-05-09 1991-04-17 Imidazopyridine PAF antagonists
PT97587A PT97587A (en) 1990-05-09 1991-05-07 PROCESS FOR THE PREPARATION OF ANTAGONISTS OF THE ACTIVATION FACTOR OF IMIDAZOPYRIDINE PLATELETS
IE155291A IE911552A1 (en) 1990-05-09 1991-05-08 Imidazopyridine paf antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010404A GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9010404D0 true GB9010404D0 (en) 1990-06-27

Family

ID=10675702

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909010404A Pending GB9010404D0 (en) 1990-05-09 1990-05-09 Therapeutic agents

Country Status (8)

Country Link
EP (1) EP0530207A1 (en)
JP (1) JPH05505199A (en)
CA (1) CA2078007A1 (en)
FI (1) FI925054A7 (en)
GB (1) GB9010404D0 (en)
IE (1) IE911552A1 (en)
PT (1) PT97587A (en)
WO (1) WO1991017162A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
CA2391498A1 (en) 1999-11-18 2001-05-25 Antexpharma, Inc. Substituted 1-benzazepines and derivatives thereof
US6242461B1 (en) * 2000-01-25 2001-06-05 Pfizer Inc. Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases
HN2001000224A (en) * 2000-10-19 2002-06-13 Pfizer IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS.
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
TW200505450A (en) 2003-02-03 2005-02-16 Janssen Pharmaceutica Nv Quinoline-derived amide modulators of vanilloid VR1 receptor
US7449481B2 (en) 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
TW200538453A (en) 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
US7709518B2 (en) * 2004-09-21 2010-05-04 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
GB0507575D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2007034277A1 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
CA2666116A1 (en) 2006-10-16 2008-04-24 Novartis Ag Phenylacetamides useful as protein kinase inhibitors
EP2651930B1 (en) * 2010-12-16 2015-10-28 Boehringer Ingelheim International GmbH Biarylamide inhibitors of leukotriene production
CN103929961A (en) * 2011-06-20 2014-07-16 美国阿尔茨海默病研究所公司 Compounds and therapeutic uses thereof
EP3181558A1 (en) 2012-12-19 2017-06-21 Basf Se Substituted [1,2,4]triazole compounds and their use as fungicides
EP3452477B1 (en) * 2016-05-04 2023-09-13 B.C.I. Pharma Adenine derivatives as protein kinase inhibitors
CN114262322A (en) * 2020-09-16 2022-04-01 中国科学院上海有机化学研究所 A kind of cell programmed necrosis inhibitor and preparation method and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104933A (en) * 1987-09-30 1994-07-30 Pfizer Ltd Platelet activating factor antagonists
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GB8905130D0 (en) * 1989-03-07 1989-04-19 Pfizer Ltd Therapeutic agents
EP0389189B1 (en) * 1989-03-23 1994-05-18 Pfizer Limited Diazepine antiallergy agents

Also Published As

Publication number Publication date
WO1991017162A1 (en) 1991-11-14
FI925054L (en) 1992-11-06
CA2078007A1 (en) 1991-11-10
IE911552A1 (en) 1991-11-20
JPH05505199A (en) 1993-08-05
EP0530207A1 (en) 1993-03-10
PT97587A (en) 1992-02-28
FI925054A0 (en) 1992-11-06
FI925054A7 (en) 1992-11-06

Similar Documents

Publication Publication Date Title
GB9010404D0 (en) Therapeutic agents
GB9018139D0 (en) Therapeutic agents
GB9000725D0 (en) Therapeutic agents
GB9004260D0 (en) Therapeutic agents
GB9024345D0 (en) Therapeutic agents
GB9014061D0 (en) Therapeutic agents
GB9019833D0 (en) Therapeutic agents
GB9019409D0 (en) Therapeutic agents
GB9015524D0 (en) Therapeutic agents
GB9016655D0 (en) Therapeutic agents
GB9002423D0 (en) Therapeutic agents
GB9007837D0 (en) Therapeutic agents
GB9005640D0 (en) Therapeutic agents
GB9014125D0 (en) Therapeutic agents
GB9002315D0 (en) Therapeutic agents
GB9002316D0 (en) Therapeutic agents
GB9002317D0 (en) Therapeutic agents
GB9002318D0 (en) Therapeutic agents
GB9002319D0 (en) Therapeutic agents
GB9002424D0 (en) Therapeutic agents
GB9002426D0 (en) Therapeutic agents
GB9002428D0 (en) Therapeutic agents
GB9003732D0 (en) Therapeutic agents
GB9004900D0 (en) Therapeutic agents
GB9000348D0 (en) Therapeutic agents